APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hematopoietic Stem Cells Transplantation

Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.

Selected research

Market Analysis & Forecast

Global Hematopoietic Stem Cells Transplantation Market Analysis and Forecast 2026-2032

Report ID 173894400227 December 2025194 pages

Choose your research edition.

Industry ResearchHematopoietic Stem Cells Transplantation Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Hematopoietic Stem Cells Transplantation Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Hematopoietic Stem Cells Transplantation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hematopoietic Stem Cells Transplantation Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Hematopoietic Stem Cells Transplantation Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.

Market competition is intense. CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Top 5 players accounted for about 32.09% market share.

Report Includes

Read the full market overview

This report presents an overview of global market for Hematopoietic Stem Cells Transplantation, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hematopoietic Stem Cells Transplantation, also provides the revenue of main regions and countries. Of the upcoming market potential for Hematopoietic Stem Cells Transplantation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hematopoietic Stem Cells Transplantation revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hematopoietic Stem Cells Transplantation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Hematopoietic Stem Cells Transplantation revenue, projected growth trends, production technology, application and end-user industry.

Hematopoietic Stem Cells Transplantation Segment by Company

CBR Systems

China Cord Blood Corporation

ViaCord

Thermo Fisher Scientific

STEMCELL Technologies

Vcanbio

Merck Millipore

Lonza Group

CellGenix Technologie Transfer

ThermoGenesis

Hematopoietic Stem Cells Transplantation Segment by Type

Stem Cells Storage

Stem Cells Consumables

Hematopoietic Stem Cells Transplantation Segment by Application

Leukemia

Lymphoproliferative Disorders

Solid Tumors

Non-Malignant Disorders

Hematopoietic Stem Cells Transplantation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hematopoietic Stem Cells Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hematopoietic Stem Cells Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hematopoietic Stem Cells Transplantation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Hematopoietic Stem Cells Transplantation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Hematopoietic Stem Cells Transplantation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hematopoietic Stem Cells Transplantation revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hematopoietic Stem Cells Transplantation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Stem Cells Storage Major Player Table 3. Stem Cells Consumables Major Player Table 4. Global Hematopoietic Stem Cells Transplantation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Leukemia Major Player Table 6. Lymphoproliferative Disorders Major Player Table 7. Solid Tumors Major Player Table 8. Non-Malignant Disorders Major Player Table 9. Hematopoietic Stem Cells Transplantation Industry Trends Table 10. Hematopoietic Stem Cells Transplantation Industry Drivers Table 11. Hematopoietic Stem Cells Transplantation Industry Opportunities and Challenges Table 12. Hematopoietic Stem Cells Transplantation Industry Restraints Table 13. Global Hematopoietic Stem Cells Transplantation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Hematopoietic Stem Cells Transplantation Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Hematopoietic Stem Cells Transplantation Market Share by Region (2021-2026) Table 16. Global Hematopoietic Stem Cells Transplantation Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Hematopoietic Stem Cells Transplantation Market Share by Region (2027-2032) Table 18. Global Hematopoietic Stem Cells Transplantation Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Players (2021-2026) Table 20. Global Hematopoietic Stem Cells Transplantation Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Hematopoietic Stem Cells Transplantation Key Players Headquarters & Area Served Table 22. Global Hematopoietic Stem Cells Transplantation Players, Product Type & Application Table 23. Global Hematopoietic Stem Cells Transplantation Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Hematopoietic Stem Cells Transplantation by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Hematopoietic Stem Cells Transplantation Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Hematopoietic Stem Cells Transplantation Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Type (2021-2026) Table 30. Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Type (2027-2032) Table 31. Global Hematopoietic Stem Cells Transplantation Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Hematopoietic Stem Cells Transplantation Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Application (2021-2026) Table 35. Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Application (2027-2032) Table 36. CBR Systems Company Information Table 37. CBR Systems Business Overview Table 38. CBR Systems Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. CBR Systems Hematopoietic Stem Cells Transplantation Product Portfolio Table 40. CBR Systems Recent Development Table 41. China Cord Blood Corporation Company Information Table 42. China Cord Blood Corporation Business Overview Table 43. China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Product Portfolio Table 45. China Cord Blood Corporation Recent Development Table 46. ViaCord Company Information Table 47. ViaCord Business Overview Table 48. ViaCord Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. ViaCord Hematopoietic Stem Cells Transplantation Product Portfolio Table 50. ViaCord Recent Development Table 51. Thermo Fisher Scientific Company Information Table 52. Thermo Fisher Scientific Business Overview Table 53. Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Product Portfolio Table 55. Thermo Fisher Scientific Recent Development Table 56. STEMCELL Technologies Company Information Table 57. STEMCELL Technologies Business Overview Table 58. STEMCELL Technologies Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. STEMCELL Technologies Hematopoietic Stem Cells Transplantation Product Portfolio Table 60. STEMCELL Technologies Recent Development Table 61. Vcanbio Company Information Table 62. Vcanbio Business Overview Table 63. Vcanbio Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Vcanbio Hematopoietic Stem Cells Transplantation Product Portfolio Table 65. Vcanbio Recent Development Table 66. Merck Millipore Company Information Table 67. Merck Millipore Business Overview Table 68. Merck Millipore Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Merck Millipore Hematopoietic Stem Cells Transplantation Product Portfolio Table 70. Merck Millipore Recent Development Table 71. Lonza Group Company Information Table 72. Lonza Group Business Overview Table 73. Lonza Group Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Lonza Group Hematopoietic Stem Cells Transplantation Product Portfolio Table 75. Lonza Group Recent Development Table 76. CellGenix Technologie Transfer Company Information Table 77. CellGenix Technologie Transfer Business Overview Table 78. CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Product Portfolio Table 80. CellGenix Technologie Transfer Recent Development Table 81. ThermoGenesis Company Information Table 82. ThermoGenesis Business Overview Table 83. ThermoGenesis Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. ThermoGenesis Hematopoietic Stem Cells Transplantation Product Portfolio Table 85. ThermoGenesis Recent Development Table 86. North America Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Hematopoietic Stem Cells Transplantation Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Hematopoietic Stem Cells Transplantation Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Hematopoietic Stem Cells Transplantation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Hematopoietic Stem Cells Transplantation Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Hematopoietic Stem Cells Transplantation Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Hematopoietic Stem Cells Transplantation Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Hematopoietic Stem Cells Transplantation Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Hematopoietic Stem Cells Transplantation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Hematopoietic Stem Cells Transplantation Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Hematopoietic Stem Cells Transplantation Revenue by Country (US$ Million) & (2027-2032) Table 100. China Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2026) & (US$ Million) Table 101. China Hematopoietic Stem Cells Transplantation Revenue by Type (2027-2032) & (US$ Million) Table 102. China Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2026) & (US$ Million) Table 103. China Hematopoietic Stem Cells Transplantation Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Hematopoietic Stem Cells Transplantation Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Hematopoietic Stem Cells Transplantation Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Hematopoietic Stem Cells Transplantation Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Hematopoietic Stem Cells Transplantation Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Hematopoietic Stem Cells Transplantation Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Hematopoietic Stem Cells Transplantation Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Hematopoietic Stem Cells Transplantation Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Hematopoietic Stem Cells Transplantation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Hematopoietic Stem Cells Transplantation Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Hematopoietic Stem Cells Transplantation Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Hematopoietic Stem Cells Transplantation Image Figure 2. Global Hematopoietic Stem Cells Transplantation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hematopoietic Stem Cells Transplantation Market Size Share 2021 VS 2025 VS 2032 Figure 4. Stem Cells Storage Image Figure 5. Stem Cells Consumables Image Figure 6. Global Hematopoietic Stem Cells Transplantation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Hematopoietic Stem Cells Transplantation Market Size Share 2021 VS 2025 VS 2032 Figure 8. Leukemia Image Figure 9. Lymphoproliferative Disorders Image Figure 10. Solid Tumors Image Figure 11. Non-Malignant Disorders Image Figure 12. Global Hematopoietic Stem Cells Transplantation Market Size (US$ Million) & (2021-2032) Figure 13. Global Hematopoietic Stem Cells Transplantation Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Hematopoietic Stem Cells Transplantation Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Hematopoietic Stem Cells Transplantation Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Hematopoietic Stem Cells Transplantation Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Hematopoietic Stem Cells Transplantation Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Type (2021-2032) Figure 20. Global Hematopoietic Stem Cells Transplantation Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Application (2021-2032) Figure 23. North America Hematopoietic Stem Cells Transplantation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Hematopoietic Stem Cells Transplantation Revenue Share by Type (2021-2032) Figure 25. North America Hematopoietic Stem Cells Transplantation Revenue Share by Application (2021-2032) Figure 26. North America Hematopoietic Stem Cells Transplantation Revenue Share by Country (2021-2032) Figure 27. United States Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Hematopoietic Stem Cells Transplantation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Hematopoietic Stem Cells Transplantation Revenue Share by Type (2021-2032) Figure 32. Europe Hematopoietic Stem Cells Transplantation Revenue Share by Application (2021-2032) Figure 33. Europe Hematopoietic Stem Cells Transplantation Revenue Share by Country (2021-2032) Figure 34. Germany Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Hematopoietic Stem Cells Transplantation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Hematopoietic Stem Cells Transplantation Revenue Share by Type (2021-2032) Figure 44. China Hematopoietic Stem Cells Transplantation Revenue Share by Application (2021-2032) Figure 45. Asia Hematopoietic Stem Cells Transplantation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Hematopoietic Stem Cells Transplantation Revenue Share by Type (2021-2032) Figure 47. Asia Hematopoietic Stem Cells Transplantation Revenue Share by Application (2021-2032) Figure 48. Asia Hematopoietic Stem Cells Transplantation Revenue Share by Region (2021-2032) Figure 49. Japan Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Hematopoietic Stem Cells Transplantation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Hematopoietic Stem Cells Transplantation Revenue Share by Type (2021-2032) Figure 57. SAMEA Hematopoietic Stem Cells Transplantation Revenue Share by Application (2021-2032) Figure 58. SAMEA Hematopoietic Stem Cells Transplantation Revenue Share by Country (2021-2032) Figure 59. Brazil Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Hematopoietic Stem Cells Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Stem Cells Storage
  • Stem Cells Consumables
Applications
  • Leukemia
  • Lymphoproliferative Disorders
  • Solid Tumors
  • Non-Malignant Disorders
Companies covered
  • CBR Systems
  • China Cord Blood Corporation
  • ViaCord
  • Thermo Fisher Scientific
  • STEMCELL Technologies
  • Vcanbio
  • Merck Millipore
  • Lonza Group
  • CellGenix Technologie Transfer
  • ThermoGenesis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hematopoietic Stem Cells Transplantation Market by Type
  3. 1.2.1 Global Hematopoietic Stem Cells Transplantation Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Stem Cells Storage
  5. 1.2.3 Stem Cells Consumables
  6. 1.3 Hematopoietic Stem Cells Transplantation Market by Application
  7. 1.3.1 Global Hematopoietic Stem Cells Transplantation Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Leukemia
  9. 1.3.3 Lymphoproliferative Disorders
  10. 1.3.4 Solid Tumors
  11. 1.3.5 Non-Malignant Disorders
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Hematopoietic Stem Cells Transplantation Market Dynamics
  1. 2.1 Hematopoietic Stem Cells Transplantation Industry Trends
  2. 2.2 Hematopoietic Stem Cells Transplantation Industry Drivers
  3. 2.3 Hematopoietic Stem Cells Transplantation Industry Opportunities and Challenges
  4. 2.4 Hematopoietic Stem Cells Transplantation Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Hematopoietic Stem Cells Transplantation Market Perspective (2021-2032)
  2. 3.2 Global Hematopoietic Stem Cells Transplantation Growth Trends by Region
  3. 3.2.1 Global Hematopoietic Stem Cells Transplantation Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hematopoietic Stem Cells Transplantation Market Size by Region (2021-2026)
  5. 3.2.3 Global Hematopoietic Stem Cells Transplantation Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Hematopoietic Stem Cells Transplantation Revenue by Players
  2. 4.1.1 Global Hematopoietic Stem Cells Transplantation Revenue by Players (2021-2026)
  3. 4.1.2 Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Hematopoietic Stem Cells Transplantation Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hematopoietic Stem Cells Transplantation Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Hematopoietic Stem Cells Transplantation Key Players Headquarters & Area Served
  7. 4.4 Global Hematopoietic Stem Cells Transplantation Players, Product Type & Application
  8. 4.5 Global Hematopoietic Stem Cells Transplantation Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Hematopoietic Stem Cells Transplantation Market CR5 and HHI
  11. 4.6.3 2025 Hematopoietic Stem Cells Transplantation Tier 1, Tier 2, and Tier 3
5 Hematopoietic Stem Cells Transplantation Market Size by Type
  1. 5.1 Global Hematopoietic Stem Cells Transplantation Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2032)
  3. 5.3 Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Type (2021-2032)
6 Hematopoietic Stem Cells Transplantation Market Size by Application
  1. 6.1 Global Hematopoietic Stem Cells Transplantation Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2032)
  3. 6.3 Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 CBR Systems
  2. 7.1.1 CBR Systems Company Information
  3. 7.1.2 CBR Systems Business Overview
  4. 7.1.3 CBR Systems Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  5. 7.1.4 CBR Systems Hematopoietic Stem Cells Transplantation Product Portfolio
  6. 7.1.5 CBR Systems Recent Developments
  7. 7.2 China Cord Blood Corporation
  8. 7.2.1 China Cord Blood Corporation Company Information
  9. 7.2.2 China Cord Blood Corporation Business Overview
  10. 7.2.3 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  11. 7.2.4 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Product Portfolio
  12. 7.2.5 China Cord Blood Corporation Recent Developments
  13. 7.3 ViaCord
  14. 7.3.1 ViaCord Company Information
  15. 7.3.2 ViaCord Business Overview
  16. 7.3.3 ViaCord Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  17. 7.3.4 ViaCord Hematopoietic Stem Cells Transplantation Product Portfolio
  18. 7.3.5 ViaCord Recent Developments
  19. 7.4 Thermo Fisher Scientific
  20. 7.4.1 Thermo Fisher Scientific Company Information
  21. 7.4.2 Thermo Fisher Scientific Business Overview
  22. 7.4.3 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Product Portfolio
  24. 7.4.5 Thermo Fisher Scientific Recent Developments
  25. 7.5 STEMCELL Technologies
  26. 7.5.1 STEMCELL Technologies Company Information
  27. 7.5.2 STEMCELL Technologies Business Overview
  28. 7.5.3 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  29. 7.5.4 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Product Portfolio
  30. 7.5.5 STEMCELL Technologies Recent Developments
  31. 7.6 Vcanbio
  32. 7.6.1 Vcanbio Company Information
  33. 7.6.2 Vcanbio Business Overview
  34. 7.6.3 Vcanbio Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Vcanbio Hematopoietic Stem Cells Transplantation Product Portfolio
  36. 7.6.5 Vcanbio Recent Developments
  37. 7.7 Merck Millipore
  38. 7.7.1 Merck Millipore Company Information
  39. 7.7.2 Merck Millipore Business Overview
  40. 7.7.3 Merck Millipore Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Merck Millipore Hematopoietic Stem Cells Transplantation Product Portfolio
  42. 7.7.5 Merck Millipore Recent Developments
  43. 7.8 Lonza Group
  44. 7.8.1 Lonza Group Company Information
  45. 7.8.2 Lonza Group Business Overview
  46. 7.8.3 Lonza Group Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Lonza Group Hematopoietic Stem Cells Transplantation Product Portfolio
  48. 7.8.5 Lonza Group Recent Developments
  49. 7.9 CellGenix Technologie Transfer
  50. 7.9.1 CellGenix Technologie Transfer Company Information
  51. 7.9.2 CellGenix Technologie Transfer Business Overview
  52. 7.9.3 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  53. 7.9.4 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Product Portfolio
  54. 7.9.5 CellGenix Technologie Transfer Recent Developments
  55. 7.10 ThermoGenesis
  56. 7.10.1 ThermoGenesis Company Information
  57. 7.10.2 ThermoGenesis Business Overview
  58. 7.10.3 ThermoGenesis Hematopoietic Stem Cells Transplantation Revenue and Gross Margin (2021-2026)
  59. 7.10.4 ThermoGenesis Hematopoietic Stem Cells Transplantation Product Portfolio
  60. 7.10.5 ThermoGenesis Recent Developments
8 North America
  1. 8.1 North America Hematopoietic Stem Cells Transplantation Revenue (2021-2032)
  2. 8.2 North America Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2032)
  3. 8.2.1 North America Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2026)
  4. 8.2.2 North America Hematopoietic Stem Cells Transplantation Revenue by Type (2027-2032)
  5. 8.3 North America Hematopoietic Stem Cells Transplantation Revenue Share by Type (2021-2032)
  6. 8.4 North America Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2032)
  7. 8.4.1 North America Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2026)
  8. 8.4.2 North America Hematopoietic Stem Cells Transplantation Revenue by Application (2027-2032)
  9. 8.5 North America Hematopoietic Stem Cells Transplantation Revenue Share by Application (2021-2032)
  10. 8.6 North America Hematopoietic Stem Cells Transplantation Revenue by Country
  11. 8.6.1 North America Hematopoietic Stem Cells Transplantation Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Hematopoietic Stem Cells Transplantation Revenue by Country (2021-2026)
  13. 8.6.3 North America Hematopoietic Stem Cells Transplantation Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Hematopoietic Stem Cells Transplantation Revenue (2021-2032)
  2. 9.2 Europe Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2032)
  3. 9.2.1 Europe Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2026)
  4. 9.2.2 Europe Hematopoietic Stem Cells Transplantation Revenue by Type (2027-2032)
  5. 9.3 Europe Hematopoietic Stem Cells Transplantation Revenue Share by Type (2021-2032)
  6. 9.4 Europe Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2032)
  7. 9.4.1 Europe Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2026)
  8. 9.4.2 Europe Hematopoietic Stem Cells Transplantation Revenue by Application (2027-2032)
  9. 9.5 Europe Hematopoietic Stem Cells Transplantation Revenue Share by Application (2021-2032)
  10. 9.6 Europe Hematopoietic Stem Cells Transplantation Revenue by Country
  11. 9.6.1 Europe Hematopoietic Stem Cells Transplantation Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Hematopoietic Stem Cells Transplantation Revenue by Country (2021-2026)
  13. 9.6.3 Europe Hematopoietic Stem Cells Transplantation Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Hematopoietic Stem Cells Transplantation Revenue (2021-2032)
  2. 10.2 China Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2032)
  3. 10.2.1 China Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2026)
  4. 10.2.2 China Hematopoietic Stem Cells Transplantation Revenue by Type (2027-2032)
  5. 10.3 China Hematopoietic Stem Cells Transplantation Revenue Share by Type (2021-2032)
  6. 10.4 China Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2032)
  7. 10.4.1 China Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2026)
  8. 10.4.2 China Hematopoietic Stem Cells Transplantation Revenue by Application (2027-2032)
  9. 10.5 China Hematopoietic Stem Cells Transplantation Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hematopoietic Stem Cells Transplantation Revenue (2021-2032)
  2. 11.2 Asia Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2032)
  3. 11.2.1 Asia Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2026)
  4. 11.2.2 Asia Hematopoietic Stem Cells Transplantation Revenue by Type (2027-2032)
  5. 11.3 Asia Hematopoietic Stem Cells Transplantation Revenue Share by Type (2021-2032)
  6. 11.4 Asia Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2032)
  7. 11.4.1 Asia Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2026)
  8. 11.4.2 Asia Hematopoietic Stem Cells Transplantation Revenue by Application (2027-2032)
  9. 11.5 Asia Hematopoietic Stem Cells Transplantation Revenue Share by Application (2021-2032)
  10. 11.6 Asia Hematopoietic Stem Cells Transplantation Revenue by Country
  11. 11.6.1 Asia Hematopoietic Stem Cells Transplantation Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Hematopoietic Stem Cells Transplantation Revenue by Country (2021-2026)
  13. 11.6.3 Asia Hematopoietic Stem Cells Transplantation Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hematopoietic Stem Cells Transplantation Revenue (2021-2032)
  2. 12.2 SAMEA Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Hematopoietic Stem Cells Transplantation Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Hematopoietic Stem Cells Transplantation Revenue by Type (2027-2032)
  5. 12.3 SAMEA Hematopoietic Stem Cells Transplantation Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Hematopoietic Stem Cells Transplantation Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Hematopoietic Stem Cells Transplantation Revenue by Application (2027-2032)
  9. 12.5 SAMEA Hematopoietic Stem Cells Transplantation Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Hematopoietic Stem Cells Transplantation Revenue by Country
  11. 12.6.1 SAMEA Hematopoietic Stem Cells Transplantation Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Hematopoietic Stem Cells Transplantation Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Hematopoietic Stem Cells Transplantation Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst